Join the AgeneBio team at these upcoming industry events.

November 7, 2015

Clinical Trials on Alzheimer’s Disease (CTAD)

Clinical Trial in MCI Reducing Hippocampal Overactivity: HOPE4MCI AgeneBio’s Michela Gallagher and Sharon Rosenzweig-Lipson to present in Barcelona on Saturday, November 7, 2015, at 11:45 am

October 6, 2015

BIO Investor Forum

October 20-21, 2015, San Francisco, CA. CEO Jerry McLaughlin will speak on Wednesday, October 21, at 9 am Pacific time.

September 30, 2015

USAgainstAlzheimer’s Summit

AgeneBio’s Michela Gallagher spoke on the impact and role of NIH funding on advances in science and clinical trials targeting the prevention of Alzheimer’s disease on Wednesday, September 30, 2015,  in Washington, DC.